PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Aerivio Spiromax (Fluticasone/Salmeterol) DPI - Chronic Obstructive Pulmonary Disease (COPD)

PAD Profile : Aerivio Spiromax (Fluticasone/Salmeterol) DPI - Chronic Obstructive Pulmonary Disease (COPD)

Keywords :
LABA, ICS, Inhaled Corticosteroids, ICSLABAs, ICS/LABAs

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
04 March 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Aerivio Spiromax (and other fluticasone containing ICS/LABAs) is NOT a locally preferred device although there is no expectation for existing stable patients to change drug or device unless agreed as a clinically appropriate course of action.

The locally preferred ICS/LABA devices are as follows:

Low carbon:

  • Fostair Nexthaler (beclometasone / formoterol DPI)
  • Fobumix Easyhaler (budesonide / formoterol DPI)
  • Relvar Ellipta (Fluticasone / vilanterol DPI)
  • Symbicort Turbohaler (budesonide / formoterol DPI)

Alternative devices:

  • Fostair (beclometasone / formoterol pMDI)
  • Symbicort (budesonide / formoterol pMDI)

Devices should be prescribed by BRAND

A spacer device should be used with MDI devices.

See full COPD guidelines below

Associated BNF Codes

03. Respiratory System
03.02.00. Corticosteroids (respiratory)
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More